Zioglim-M3 FORTE helps manage type 2 diabetes by combining Metformin Hydrochloride Prolonged Release and Glimepiride. Metformin improves insulin sensitivity and reduces glucose production in the liver, while Glimepiride stimulates the pancreas to release more insulin. This dual action effectively controls blood sugar levels and reduces the risk of diabetes-related complications. Zioglim-M3 FORTE is ideal for patients who need a combination therapy to achieve better glycemic control. Always use under medical supervision for optimal results in diabetes management.